Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-23-029612

Options or other derivatives

  • Chief Development Officer acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jalota Deepika · Chief Development Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-12 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +125,000 125,000 D
Loading xslF345X04/doc4.xml…